Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PETITE study of brivaracetam in neonates with repeated electroencephalographic seizures
NL-OMON50223Phase 2Withdrawn
- Sponsor
- UCB
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of brivaracetam in neonatal seizure and seizure disorder, sponsored by UCB. Planned start Apr 2017; status: withdrawn.
02
Drugs
brivaracetam
03
Conditions
neonatal seizureseizure disorder
Beyond the preview
Go deeper on NL-OMON50223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50223.